| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry [M. T., H-O. P., M. E., A. K., F. S.] and the First Department of Anatomy [Y. T.], Osaka University Faculty of Dentistry, Suita, Osaka 565; Saiseikai Nakatsu Hospital, Osaka 530 [K. T.]; and Department of Cell Biology, Research Institute, Center for Adult Diseases, Osaka 537 [Y. M.], Japan
A clonal cell line with cartilage phenotypes and tumorigenicity during more than 3 years in culture was established from a human chondrosarcoma. In sparse cultures, the clonal line, named HCS-2/8, consisted of slightly elongated polygonal cells, which proliferated with a doubling time of 3.5 days. The cells became polygonal to spherical as they became confluent. After reaching confluence, the cells continued to proliferate slowly and formed nodules, which showed metachromasia when stained with toluidine blue. The nodules were three-dimensional in structure; cells were multilayered in the surface regions, overlying a thick layer of extracellular matrix, which showed metachromasia. Electron microscopically, the cells resembling chondrocytes in vivo were surrounded by an extracellular matrix consisting of thin collagen-like fibrils with numerous fine granules, presumably of proteoglycans. The cells actively synthesized proteoglycans as determined by [35S]sulfate incorporation. The hydrodynamic size of major proteoglycan monomers synthesized by the cells was that of so-called cartilage-specific proteoglycans, as determined by glycerol gradient centrifugation. Immunostaining identified type II collagen but not type I collagen. Fluorography and immunoblotting of collagens separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis also demonstrated the synthesis of type II collagen but not type I collagen. Inoculation of HCS-2/8 cells into athymic mice resulted in the formation of chondrosarcomas that resembled the original tumor. Because of having these characters, HCS-2/8 cells should be useful not only in studies on the differentiated phenotypes of human chondrocytes but also in basic studies on the diagnosis, treatment, and etiology of human chondrosarcomas.
1 Supported in part by Grants-in-Aid for Scientific Research (to M. T. and F. S) and Developmental Scientific Research (to M. T.) from the Ministry of Education, Science and Culture of Japan, and by grants from the Kudo Scientific Foundation (to M. T.), the Kowa Life Science Foundation (to M. T.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to F. S.), the Asahi Scholarship Promotion Fund (to F. S., M. T., M. E.), the Research Foundation for Cancer and Cardiovascular Diseases (to M. T.), and the Osaka Anti-Cancer Society (to M. T. and M. E.).
2 To whom requests for reprints should be addressed.
3 Present address: The Second Department of Oral Anatomy, School of Dentistry, Hokkaido University, Sapporo, Hokkaido 060, Japan.
Received 9/21/88. Revised 3/ 3/89. Accepted 4/ 3/89.
This article has been cited by other articles:
![]() |
M. Oka, S. Kubota, S. Kondo, T. Eguchi, C. Kuroda, K. Kawata, S. Minagi, and M. Takigawa Gene Expression and Distribution of Connective Tissue Growth Factor (CCN2/CTGF) During Secondary Ossification Center Formation J. Histochem. Cytochem., December 1, 2007; 55(12): 1245 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zaman, V. Menendez-Benito, E. Eriksson, A. S. Chagin, M. Takigawa, B. Fadeel, N. P. Dantuma, D. Chrysis, and L. Savendahl Proteasome Inhibition Up-regulates p53 and Apoptosis-Inducing Factor in Chondrocytes Causing Severe Growth Retardation in Mice Cancer Res., October 15, 2007; 67(20): 10078 - 10086. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Masuya, K. Nishida, T. Furuichi, H. Toki, G. Nishimura, H. Kawabata, H. Yokoyama, A. Yoshida, S. Tominaga, J. Nagano, et al. A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice Hum. Mol. Genet., October 1, 2007; 16(19): 2366 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A S Chagin, D Chrysis, M Takigawa, E M Ritzen, and L Savendahl Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis J. Endocrinol., February 1, 2006; 188(2): 193 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, T. Yagyu, T. Kondo, N. Kurita, K. Inagaki, S. Haruta, R. Kawaguchi, T. Kitanaka, Y. Sakamoto, Y. Yamada, et al. Suppression of Urokinase Receptor Expression by Thalidomide Is Associated with Inhibition of Nuclear Factor {kappa}B Activation and Subsequently Suppressed Ovarian Cancer Dissemination Cancer Res., November 15, 2005; 65(22): 10464 - 10471. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chrysis, F. Zaman, A. S. Chagin, M. Takigawa, and L. Savendahl Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3'-Kinase Signaling Pathway Endocrinology, March 1, 2005; 146(3): 1391 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Minato, S. Kubota, H. Kawaki, T. Nishida, A. Miyauchi, H. Hanagata, T. Nakanishi, T. Takano-Yamamoto, and M. Takigawa Module-Specific Antibodies against Human Connective Tissue Growth Factor: Utility for Structural and Functional Analysis of the Factor as Related to Chondrocytes J. Biochem., March 1, 2004; 135(3): 347 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rilla, M. J. Lammi, R. Sironen, K. Torronen, M. Luukkonen, V. C. Hascall, R. J. Midura, M. Hyttinen, J. Pelkonen, M. Tammi, et al. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes J. Cell Sci., September 15, 2002; 115(18): 3633 - 3643. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Sekine, K Masuko-Hongo, T Matsui, H Asahara, M Takigawa, K Nishioka, and T Kato Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis Ann Rheum Dis, January 1, 2001; 60(1): 49 - 54. [Abstract] [Full Text] |
||||
![]() |
T. Nakanishi, T. Nishida, T. Shimo, K. Kobayashi, T. Kubo, T. Tamatani, K. Tezuka, and M. Takigawa Effects of CTGF/Hcs24, a Product of a Hypertrophic Chondrocyte-Specific Gene, on the Proliferation and Differentiation of Chondrocytes in Culture Endocrinology, January 1, 2000; 141(1): 264 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Uria, M. Balbin, J. M. Lopez, J. Alvarez, F. Vizoso, M. Takigawa, and C. Lopez-Otin Collagenase-3 (MMP-13) Expression in Chondrosarcoma Cells and Its Regulation by Basic Fibroblast Growth Factor Am. J. Pathol., July 1, 1998; 153(1): 91 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, T. Kubo, Y. Arai, I. Kitajima, M. Takigawa, J. Imanishi, and Y. Hirasawa Hydrostatic pressure induces expression of interleukin 6 and tumour necrosis factor alpha mRNAs in a chondrocyte-like cell line Ann Rheum Dis, April 1, 1998; 57(4): 231 - 236. [Abstract] [Full Text] |
||||
![]() |
M. Takigawa, T. Okawa, H.-O. Pan, C. Aoki, K. Takahashi, J.-D. Zue, F. Suzuki, and A. Kinoshita Insulin-Like Growth Factors I and II Are Autocrine Factors in Stimulating Proteoglycan Synthesis, a Marker of Differentiated Chondrocytes, Acting through Their Respective Receptors on a Clonal Human Chondrosarcoma-Derived Chondrocyte Cell Line, HCS-2/8 Endocrinology, October 1, 1997; 138(10): 4390 - 4400. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tuckwell, S Ayad, M. Grant, M Takigawa, and M. Humphries Conformation dependence of integrin-type II collagen binding. Inability of collagen peptides to support alpha 2 beta 1 binding, and mediation of adhesion to denatured collagen by a novel alpha 5 beta 1-fibronectin bridge J. Cell Sci., January 4, 1994; 107(4): 993 - 1005. [Abstract] [PDF] |
||||
![]() |
C. Ghayor, J.-F. Herrouin, C. Chadjichristos, L. Ala-Kokko, M. Takigawa, J.-P. Pujol, and P. Galera Regulation of Human COL2A1 Gene Expression in Chondrocytes. IDENTIFICATION OF C-Krox-RESPONSIVE ELEMENTS AND MODULATION BY PHENOTYPE ALTERATION J. Biol. Chem., August 25, 2000; 275(35): 27421 - 27438. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ghayor, C. Chadjichristos, J.-F. Herrouin, L. Ala-Kokko, G. Suske, J.-P. Pujol, and P. Galera SP3 Represses the SP1-mediated Transactivation of the Human COL2A1 Gene in Primary and De-differentiated Chondrocytes J. Biol. Chem., September 28, 2001; 276(40): 36881 - 36895. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, Y. Hirashima, G. W. Sun, M. Fujie, T. Nishida, M. Takigawa, and T. Terao Identity of Urinary Trypsin Inhibitor-binding Protein to Link Protein J. Biol. Chem., July 7, 2000; 275(28): 21185 - 21191. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |